EU drug regulator: Unusual blood clot is 'very rare AstraZeneca side effect'
The EU's medicines regulator says unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine for Covid-19.
The EU's medicines regulator says unusual blood clots should be listed as a very rare side effect of the AstraZeneca vaccine for Covid-19.
There has been chaos and confusion in Germany and Italy after their decisions to suspend use of the Oxford/AstraZeneca Covid vaccine, with vaccination centres closing their doors and appointments being abruptly cancelled.
The World Health Organization (WHO) has urged countries not to pause Covid vaccinations, as several major EU countries halted their rollouts of the Oxford-AstraZeneca jab.
The Netherlands has become the latest country to suspend use of the Oxford-AstraZeneca coronavirus vaccine over concerns about possible side effects.
The director of the Oxford vaccine group has said there was no link between the jab it developed with AstraZeneca and blood clotting, after several countries suspended its use.
Denmark temporarily stops administering Oxford/AstraZeneca vaccine
Participants will get one shot of the AstraZeneca vaccine followed by a dose from Pfizer, or vice versa.